The Story so far

About Curity

Building the future of cannabinoid medicines.

CURITY Pharma is a vertically integrated pharmaceutical company developing, producing and distributing medical cannabis products for regulated international markets.

2019 Founded with a pharmaceutical focus
67,000 m² Integrated site in Greece
5,000 m² Controlled cultivation facility
2,000 m² GMP manufacturing facility

Who we are

From cultivation to controlled pharmaceutical production.

CURITY Pharma was established to connect the biological complexity of the cannabis plant with the discipline, documentation and reliability expected from modern pharmaceutical manufacturing.

Our model brings cultivation, processing, quality systems and distribution under one coordinated operational framework. This vertical integration allows us to control critical variables from plant material to finished product, supporting consistency, traceability and compliance across every stage.

We aim to serve healthcare professionals, partners and patients through cannabinoid therapeutics developed with scientific care, manufacturing precision and long-term regulatory responsibility.

Pharmaceutical intent

Nature, translated through controlled systems.

CURITY Pharma works at the intersection of plant science, pharmaceutical technology and regulated manufacturing. Our purpose is to transform a sensitive botanical starting material into reliable cannabinoid medicines that meet defined quality expectations.

Vertical integration

One connected workflow.

By managing the chain internally, CURITY Pharma can align cultivation strategy, production planning, quality control and regulatory documentation around the same operating standards.

01

Genetics

Selection and management of plant material for defined cannabinoid and terpene profiles.

02

Cultivation

Controlled greenhouse operations supported by monitoring, traceability and repeatable process controls.

03

Processing

Pharmaceutical-grade handling and transformation inside a purpose-built manufacturing environment.

04

Quality

Documentation, testing and release processes designed for regulated product expectations.

05

Markets

Distribution planning for regulated international markets and qualified partners.

Operating commitments

Built for trust, consistency and scale.

Our work is shaped by the standards expected from serious pharmaceutical operations: controlled environments, complete records and a culture of continuous improvement.

Q

Quality by design

Processes are structured to reduce variability and support consistent product characteristics from batch to batch.

T

Traceability

Digital systems support identification, tracking and documentation across cultivation and manufacturing activities.

R

Regulatory discipline

Operations are developed with transparency, responsible governance and market-specific compliance requirements in mind.

Quality systems

Pharmaceutical standards, applied end to end.

From cultivation controls to manufacturing documentation, CURITY Pharma is building a platform for reliable, auditable medical cannabis production.

EU-GMP Manufacturing systems designed around pharmaceutical quality expectations.
GACP Cultivation practices aligned with controlled botanical production principles.
QC Quality control and release logic for consistent product assessment.
Digital Traceability, serialization and data systems supporting compliant operations.

Company path

From foundation to international expansion.

A focused development path has shaped CURITY Pharma into a vertically integrated platform for cannabinoid medicines.

Foundation CURITY Pharma founded with a pharmaceutical development vision.
Construction Purpose-built cultivation and manufacturing infrastructure developed in Greece.
Commissioning Facilities, equipment, procedures and digital systems prepared for operation.
Licensing Regulatory pathway and operational framework established for controlled production.
Production Commercial manufacturing capability focused on consistent medical cannabis products.
Expansion Development of partnerships and access to regulated international markets.

Principles

The values behind the operating system.

Science

Evidence-led development

We pursue cannabinoid medicines through research, technical evaluation and disciplined product thinking.

Precision

Controlled execution

We invest in systems that make operations measurable, repeatable and suitable for regulated environments.

Integrity

Responsible growth

We operate with transparency, ethical responsibility and respect for the local rules of every market we serve.

Patients

Purpose beyond production

Every advancement ultimately serves people who depend on safe, reliable and effective medicines.

Looking ahead

Quality of life, cultivated with purpose.

The future of medicine will increasingly combine the power of nature with the precision of pharmaceutical science. CURITY Pharma is committed to advancing cannabinoid therapeutics through scientific excellence, manufacturing innovation and uncompromising quality, creating lasting value for patients, healthcare professionals, partners and society.